Species

VETERA® GOLDXP

Combination Vaccine for Horses

Details

  • VETERA® GOLDXP has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against:
    • Eastern and western encephalomyelitis (EEE & WEE)
    • West Nile virus (WNV)
    • Tetanus
    • Respiratory disease due to equine herpesvirus types 1 and 4 (EHV-1 & EHV-4)
    • Equine influenza virus (EIV)
  • VETERA® GOLDXP has also been shown to be effective against viral shedding due to A2 EIV and against viremia, mortality, and neurological clinical disease due to WNV 
  • The VETERA® portfolio features a wide range of progressive choices and contains the most comprehensive 1 mL vaccine (VETERA® GOLDXP + VEE) on the US market
  • VETERA® was the first vaccine in the US updated to contain both Florida sublineage clade 1 and clade 2 EIV, as recommended by the World Organisation for Animal Health (WOAH) on Equine Influenza and AAEP
Features & Benefits

Features

  • Contains a combination of various antigens in one vaccine
    • Influenza
    • Herpesvirus types 1 and 4 (EHV-1 and EHV-4)
    • West Nile virus (WNV)
    • Eastern and Western Equine Encephalomyelitis (EEE and WEE)
    • Tetanus
  • Contains Kentucky lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains
  • Contains EHV-1 and EHV-4
  • Includes a unique NORTH AMERICAN EQUINE E159™ WNV strain
  • Incorporates the CARBIMMUNE® adjuvant formulation
  • ULTRAFIL® purification technology

Benefits

  • 7-way protection in one vaccine
  • CARBIMMUNE® adjuvant system allows a dual-phase antigen presentation to deliver both rapid and long-lasting immunity
  • ULTRAFIL® purification technology eliminates undesirable cellular components and extraneous protein to minimize the potential injection site reactions (such as heat, swelling, and inflammation)
  • At least 6-month duration of immunity against EIV (OH/03)
  • At least 12-month WNV duration of immunity
  • Safe for use in horses as young as 4 months of age, including pregnant mares
Dosage & Administration

Shake well before use. Using aseptic technique, inoculate horses intramuscularly (IM) with a 1 mL dose.

 

Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site.

 

The need for annual booster vaccination has not been established for this product. Consultation with a veterinarian for revaccination frequency should be considered.

Resources

Vaccines Antigen Chart

Influenza Protection Detailer

Safety Information

Precautions

  • Store at 35-46°F (2-8°C)
  • Do not freeze
  • Do not mix with other products
  • Do not vaccinate within 21 days before slaughter
  • Use entire contents when first opened

 

In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

 

Trademarks

VETERA® is a registered trademark and NORTH AMERICAN EQUINE E159™ is a trademark of Boehringer Ingelheim Vetmedica GmbH, used under license. CARBIMMUNE® is a registered trademark and ULTRAFIL™️ is a trademark of Boehringer Ingelheim Animal Health USA, Inc. ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-EQU-0104-2021-V2